Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Gastrointestinal Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Gastrointestinal Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Gastrointestinal Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
AstraZeneca
Teva
Abbott
Purdue Pharma
Perrigo
Boehringer Ingelheim
GlaxoSmithKline
Pfizer
Bayer
Sanofi
Xian-Janssen
Jiangzhong
By Type:
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
By End-User:
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Gastrointestinal Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 China Gastrointestinal Drugs Market Size and Growth Rate of Prescription Gastrointestinal Drug from 2016 to 2027
-
1.3.2 China Gastrointestinal Drugs Market Size and Growth Rate of OTC Gastrointestinal Drug from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Gastrointestinal Drugs Market Size and Growth Rate of Chronic Gastritis from 2016 to 2027
-
1.4.2 China Gastrointestinal Drugs Market Size and Growth Rate of Functional Dyspepsia from 2016 to 2027
-
1.4.3 China Gastrointestinal Drugs Market Size and Growth Rate of Peptic Ulcer from 2016 to 2027
-
1.4.4 China Gastrointestinal Drugs Market Size and Growth Rate of Acute Gastroenteritis from 2016 to 2027
-
1.4.5 China Gastrointestinal Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Gastrointestinal Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Gastrointestinal Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Prescription Gastrointestinal Drug
-
3.4.2 Market Size and Growth Rate of OTC Gastrointestinal Drug
4 Segmentation of Gastrointestinal Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Gastrointestinal Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Gastrointestinal Drugs in Chronic Gastritis
-
4.4.2 Market Size and Growth Rate of Gastrointestinal Drugs in Functional Dyspepsia
-
4.4.3 Market Size and Growth Rate of Gastrointestinal Drugs in Peptic Ulcer
-
4.4.4 Market Size and Growth Rate of Gastrointestinal Drugs in Acute Gastroenteritis
-
4.4.5 Market Size and Growth Rate of Gastrointestinal Drugs in Other
5 Market Analysis by Regions
-
5.1 China Gastrointestinal Drugs Production Analysis by Regions
-
5.2 China Gastrointestinal Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Gastrointestinal Drugs Landscape Analysis
-
6.1 North China Gastrointestinal Drugs Landscape Analysis by Major Types
-
6.2 North China Gastrointestinal Drugs Landscape Analysis by Major End-Users
7 Central China Gastrointestinal Drugs Landscape Analysis
-
7.1 Central China Gastrointestinal Drugs Landscape Analysis by Major Types
-
7.2 Central China Gastrointestinal Drugs Landscape Analysis by Major End-Users
8 South China Gastrointestinal Drugs Landscape Analysis
-
8.1 South China Gastrointestinal Drugs Landscape Analysis by Major Types
-
8.2 South China Gastrointestinal Drugs Landscape Analysis by Major End-Users
9 East China Gastrointestinal Drugs Landscape Analysis
-
9.1 East China Gastrointestinal Drugs Landscape Analysis by Major Types
-
9.2 East China Gastrointestinal Drugs Landscape Analysis by Major End-Users
10 Northeast China Gastrointestinal Drugs Landscape Analysis
-
10.1 Northeast China Gastrointestinal Drugs Landscape Analysis by Major Types
-
10.2 Northeast China Gastrointestinal Drugs Landscape Analysis by Major End-Users
11 Southwest China Gastrointestinal Drugs Landscape Analysis
-
11.1 Southwest China Gastrointestinal Drugs Landscape Analysis by Major Types
-
11.2 Southwest China Gastrointestinal Drugs Landscape Analysis by Major End-Users
12 Northwest China Gastrointestinal Drugs Landscape Analysis
-
12.1 Northwest China Gastrointestinal Drugs Landscape Analysis by Major Types
-
12.2 Northwest China Gastrointestinal Drugs Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 AstraZeneca
-
13.1.1 AstraZeneca Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Teva
-
13.2.1 Teva Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Abbott
-
13.3.1 Abbott Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Purdue Pharma
-
13.4.1 Purdue Pharma Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Perrigo
-
13.5.1 Perrigo Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Boehringer Ingelheim
-
13.6.1 Boehringer Ingelheim Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 GlaxoSmithKline
-
13.7.1 GlaxoSmithKline Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Pfizer
-
13.8.1 Pfizer Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Bayer
-
13.9.1 Bayer Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Sanofi
-
13.10.1 Sanofi Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Xian-Janssen
-
13.11.1 Xian-Janssen Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Jiangzhong
-
13.12.1 Jiangzhong Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Gastrointestinal Drugs Market Size and Growth Rate of Prescription Gastrointestinal Drug from 2016 to 2027
-
Figure China Gastrointestinal Drugs Market Size and Growth Rate of OTC Gastrointestinal Drug from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Gastrointestinal Drugs Market Size and Growth Rate of Chronic Gastritis from 2016 to 2027
-
Figure China Gastrointestinal Drugs Market Size and Growth Rate of Functional Dyspepsia from 2016 to 2027
-
Figure China Gastrointestinal Drugs Market Size and Growth Rate of Peptic Ulcer from 2016 to 2027
-
Figure China Gastrointestinal Drugs Market Size and Growth Rate of Acute Gastroenteritis from 2016 to 2027
-
Figure China Gastrointestinal Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Gastrointestinal Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Gastrointestinal Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Gastrointestinal Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Gastrointestinal Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Prescription Gastrointestinal Drug
-
Figure Market Size and Growth Rate of OTC Gastrointestinal Drug
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Gastrointestinal Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Gastrointestinal Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Chronic Gastritis
-
Figure Market Size and Growth Rate of Functional Dyspepsia
-
Figure Market Size and Growth Rate of Peptic Ulcer
-
Figure Market Size and Growth Rate of Acute Gastroenteritis
-
Figure Market Size and Growth Rate of Other
-
Table China Gastrointestinal Drugs Production by Regions
-
Table China Gastrointestinal Drugs Production Share by Regions
-
Figure China Gastrointestinal Drugs Production Share by Regions in 2016
-
Figure China Gastrointestinal Drugs Production Share by Regions in 2021
-
Figure China Gastrointestinal Drugs Production Share by Regions in 2027
-
Table China Gastrointestinal Drugs Consumption by Regions
-
Table China Gastrointestinal Drugs Consumption Share by Regions
-
Figure China Gastrointestinal Drugs Consumption Share by Regions in 2016
-
Figure China Gastrointestinal Drugs Consumption Share by Regions in 2021
-
Figure China Gastrointestinal Drugs Consumption Share by Regions in 2027
-
Table North China Gastrointestinal Drugs Consumption by Types from 2016 to 2027
-
Table North China Gastrointestinal Drugs Consumption Share by Types from 2016 to 2027
-
Figure North China Gastrointestinal Drugs Consumption Share by Types in 2016
-
Figure North China Gastrointestinal Drugs Consumption Share by Types in 2021
-
Figure North China Gastrointestinal Drugs Consumption Share by Types in 2027
-
Table North China Gastrointestinal Drugs Consumption by End-Users from 2016 to 2027
-
Table North China Gastrointestinal Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure North China Gastrointestinal Drugs Consumption Share by End-Users in 2016
-
Figure North China Gastrointestinal Drugs Consumption Share by End-Users in 2021
-
Figure North China Gastrointestinal Drugs Consumption Share by End-Users in 2027
-
Table Central China Gastrointestinal Drugs Consumption by Types from 2016 to 2027
-
Table Central China Gastrointestinal Drugs Consumption Share by Types from 2016 to 2027
-
Figure Central China Gastrointestinal Drugs Consumption Share by Types in 2016
-
Figure Central China Gastrointestinal Drugs Consumption Share by Types in 2021
-
Figure Central China Gastrointestinal Drugs Consumption Share by Types in 2027
-
Table Central China Gastrointestinal Drugs Consumption by End-Users from 2016 to 2027
-
Table Central China Gastrointestinal Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Gastrointestinal Drugs Consumption Share by End-Users in 2016
-
Figure Central China Gastrointestinal Drugs Consumption Share by End-Users in 2021
-
Figure Central China Gastrointestinal Drugs Consumption Share by End-Users in 2027
-
Table South China Gastrointestinal Drugs Consumption by Types from 2016 to 2027
-
Table South China Gastrointestinal Drugs Consumption Share by Types from 2016 to 2027
-
Figure South China Gastrointestinal Drugs Consumption Share by Types in 2016
-
Figure South China Gastrointestinal Drugs Consumption Share by Types in 2021
-
Figure South China Gastrointestinal Drugs Consumption Share by Types in 2027
-
Table South China Gastrointestinal Drugs Consumption by End-Users from 2016 to 2027
-
Table South China Gastrointestinal Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South China Gastrointestinal Drugs Consumption Share by End-Users in 2016
-
Figure South China Gastrointestinal Drugs Consumption Share by End-Users in 2021
-
Figure South China Gastrointestinal Drugs Consumption Share by End-Users in 2027
-
Table East China Gastrointestinal Drugs Consumption by Types from 2016 to 2027
-
Table East China Gastrointestinal Drugs Consumption Share by Types from 2016 to 2027
-
Figure East China Gastrointestinal Drugs Consumption Share by Types in 2016
-
Figure East China Gastrointestinal Drugs Consumption Share by Types in 2021
-
Figure East China Gastrointestinal Drugs Consumption Share by Types in 2027
-
Table East China Gastrointestinal Drugs Consumption by End-Users from 2016 to 2027
-
Table East China Gastrointestinal Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure East China Gastrointestinal Drugs Consumption Share by End-Users in 2016
-
Figure East China Gastrointestinal Drugs Consumption Share by End-Users in 2021
-
Figure East China Gastrointestinal Drugs Consumption Share by End-Users in 2027
-
Table Northeast China Gastrointestinal Drugs Consumption by Types from 2016 to 2027
-
Table Northeast China Gastrointestinal Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Gastrointestinal Drugs Consumption Share by Types in 2016
-
Figure Northeast China Gastrointestinal Drugs Consumption Share by Types in 2021
-
Figure Northeast China Gastrointestinal Drugs Consumption Share by Types in 2027
-
Table Northeast China Gastrointestinal Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast China Gastrointestinal Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Gastrointestinal Drugs Consumption Share by End-Users in 2016
-
Figure Northeast China Gastrointestinal Drugs Consumption Share by End-Users in 2021
-
Figure Northeast China Gastrointestinal Drugs Consumption Share by End-Users in 2027
-
Table Southwest China Gastrointestinal Drugs Consumption by Types from 2016 to 2027
-
Table Southwest China Gastrointestinal Drugs Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Gastrointestinal Drugs Consumption Share by Types in 2016
-
Figure Southwest China Gastrointestinal Drugs Consumption Share by Types in 2021
-
Figure Southwest China Gastrointestinal Drugs Consumption Share by Types in 2027
-
Table Southwest China Gastrointestinal Drugs Consumption by End-Users from 2016 to 2027
-
Table Southwest China Gastrointestinal Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Gastrointestinal Drugs Consumption Share by End-Users in 2016
-
Figure Southwest China Gastrointestinal Drugs Consumption Share by End-Users in 2021
-
Figure Southwest China Gastrointestinal Drugs Consumption Share by End-Users in 2027
-
Table Northwest China Gastrointestinal Drugs Consumption by Types from 2016 to 2027
-
Table Northwest China Gastrointestinal Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Gastrointestinal Drugs Consumption Share by Types in 2016
-
Figure Northwest China Gastrointestinal Drugs Consumption Share by Types in 2021
-
Figure Northwest China Gastrointestinal Drugs Consumption Share by Types in 2027
-
Table Northwest China Gastrointestinal Drugs Consumption by End-Users from 2016 to 2027
-
Table Northwest China Gastrointestinal Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Gastrointestinal Drugs Consumption Share by End-Users in 2016
-
Figure Northwest China Gastrointestinal Drugs Consumption Share by End-Users in 2021
-
Figure Northwest China Gastrointestinal Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Teva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva
-
Figure Sales and Growth Rate Analysis of Teva
-
Figure Revenue and Market Share Analysis of Teva
-
Table Product and Service Introduction of Teva
-
Table Company Profile and Development Status of Abbott
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott
-
Figure Sales and Growth Rate Analysis of Abbott
-
Figure Revenue and Market Share Analysis of Abbott
-
Table Product and Service Introduction of Abbott
-
Table Company Profile and Development Status of Purdue Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma
-
Figure Sales and Growth Rate Analysis of Purdue Pharma
-
Figure Revenue and Market Share Analysis of Purdue Pharma
-
Table Product and Service Introduction of Purdue Pharma
-
Table Company Profile and Development Status of Perrigo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Perrigo
-
Figure Sales and Growth Rate Analysis of Perrigo
-
Figure Revenue and Market Share Analysis of Perrigo
-
Table Product and Service Introduction of Perrigo
-
Table Company Profile and Development Status of Boehringer Ingelheim
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
-
Table Product and Service Introduction of Boehringer Ingelheim
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Xian-Janssen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Xian-Janssen
-
Figure Sales and Growth Rate Analysis of Xian-Janssen
-
Figure Revenue and Market Share Analysis of Xian-Janssen
-
Table Product and Service Introduction of Xian-Janssen
-
Table Company Profile and Development Status of Jiangzhong
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jiangzhong
-
Figure Sales and Growth Rate Analysis of Jiangzhong
-
Figure Revenue and Market Share Analysis of Jiangzhong
-
Table Product and Service Introduction of Jiangzhong
-
